Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Drug transporter expression and localization in rat nasal respiratory and olfactory mucosa and olfactory bulb.

Genter MB, Krishan M, Augustine LM, Cherrington NJ.

Drug Metab Dispos. 2010 Oct;38(10):1644-7. doi: 10.1124/dmd.110.034611. Epub 2010 Jul 21.

2.

Hepatic cytochrome P450 enzyme alterations in humans with progressive stages of nonalcoholic fatty liver disease.

Fisher CD, Lickteig AJ, Augustine LM, Ranger-Moore J, Jackson JP, Ferguson SS, Cherrington NJ.

Drug Metab Dispos. 2009 Oct;37(10):2087-94. doi: 10.1124/dmd.109.027466. Epub 2009 Aug 3.

3.

Effect of allyl alcohol on hepatic transporter expression: zonal patterns of expression and role of Kupffer cell function.

Campion SN, Tatis-Rios C, Augustine LM, Goedken MJ, van Rooijen N, Cherrington NJ, Manautou JE.

Toxicol Appl Pharmacol. 2009 Apr 1;236(1):49-58. doi: 10.1016/j.taap.2009.01.007. Epub 2009 Jan 24.

4.

Experimental non-alcoholic fatty liver disease results in decreased hepatic uptake transporter expression and function in rats.

Fisher CD, Lickteig AJ, Augustine LM, Oude Elferink RP, Besselsen DG, Erickson RP, Cherrington NJ.

Eur J Pharmacol. 2009 Jun 24;613(1-3):119-27. doi: 10.1016/j.ejphar.2009.04.002. Epub 2009 Apr 7.

5.

Renal xenobiotic transporters are differentially expressed in mice following cisplatin treatment.

Aleksunes LM, Augustine LM, Scheffer GL, Cherrington NJ, Manautou JE.

Toxicology. 2008 Sep 4;250(2-3):82-8. doi: 10.1016/j.tox.2008.06.009. Epub 2008 Jul 2.

6.

Tissue distribution, ontogeny and induction of the transporters Multidrug and toxin extrusion (MATE) 1 and MATE2 mRNA expression levels in mice.

Lickteig AJ, Cheng X, Augustine LM, Klaassen CD, Cherrington NJ.

Life Sci. 2008 Jul 4;83(1-2):59-64. doi: 10.1016/j.lfs.2008.05.004. Epub 2008 May 18.

7.

Drug metabolizing enzyme induction pathways in experimental non-alcoholic steatohepatitis.

Fisher CD, Jackson JP, Lickteig AJ, Augustine LM, Cherrington NJ.

Arch Toxicol. 2008 Dec;82(12):959-64. doi: 10.1007/s00204-008-0312-z. Epub 2008 May 17.

8.

The Nrf2 activator oltipraz also activates the constitutive androstane receptor.

Merrell MD, Jackson JP, Augustine LM, Fisher CD, Slitt AL, Maher JM, Huang W, Moore DD, Zhang Y, Klaassen CD, Cherrington NJ.

Drug Metab Dispos. 2008 Aug;36(8):1716-21. doi: 10.1124/dmd.108.020867. Epub 2008 May 12.

9.

Gender divergent expression of Nqo1 in Sprague Dawley and August Copenhagen x Irish rats.

Augustine LM, Fisher CD, Lickteig AJ, Aleksunes LM, Slitt AL, Cherrington NJ.

J Biochem Mol Toxicol. 2008 Mar-Apr;22(2):93-100. doi: 10.1002/jbt.20224.

PMID:
18418895
10.

Induction of drug metabolism enzymes and transporters by oltipraz in rats.

Merrell MD, Augustine LM, Slitt AL, Cherrington NJ.

J Biochem Mol Toxicol. 2008 Mar-Apr;22(2):128-35. doi: 10.1002/jbt.20225.

PMID:
18418891
11.

Induction of Mrp3 and Mrp4 transporters during acetaminophen hepatotoxicity is dependent on Nrf2.

Aleksunes LM, Slitt AL, Maher JM, Augustine LM, Goedken MJ, Chan JY, Cherrington NJ, Klaassen CD, Manautou JE.

Toxicol Appl Pharmacol. 2008 Jan 1;226(1):74-83. Epub 2007 Aug 31.

12.

Influence of acetaminophen vehicle on regulation of transporter gene expression during hepatotoxicity.

Aleksunes LM, Augustine LM, Cherrington NJ, Manautou JE.

J Toxicol Environ Health A. 2007 Nov;70(21):1870-2.

PMID:
17934960
13.

Genes of the antioxidant response undergo upregulation in a rodent model of nonalcoholic steatohepatitis.

Lickteig AJ, Fisher CD, Augustine LM, Cherrington NJ.

J Biochem Mol Toxicol. 2007;21(4):216-20.

PMID:
17721935
14.

Efflux transporter expression and acetaminophen metabolite excretion are altered in rodent models of nonalcoholic fatty liver disease.

Lickteig AJ, Fisher CD, Augustine LM, Aleksunes LM, Besselsen DG, Slitt AL, Manautou JE, Cherrington NJ.

Drug Metab Dispos. 2007 Oct;35(10):1970-8. Epub 2007 Jul 19.

PMID:
17640958
15.

Induction of drug-metabolizing enzymes by garlic and allyl sulfide compounds via activation of constitutive androstane receptor and nuclear factor E2-related factor 2.

Fisher CD, Augustine LM, Maher JM, Nelson DM, Slitt AL, Klaassen CD, Lehman-McKeeman LD, Cherrington NJ.

Drug Metab Dispos. 2007 Jun;35(6):995-1000. Epub 2007 Mar 12.

PMID:
17353348
16.

Xenobiotic and endobiotic transporter mRNA expression in the blood-testis barrier.

Augustine LM, Markelewicz RJ Jr, Boekelheide K, Cherrington NJ.

Drug Metab Dispos. 2005 Jan;33(1):182-9. Epub 2004 Oct 19.

PMID:
15494472

Supplemental Content

Loading ...
Support Center